BlackRock, Inc. 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-25 6:35 pm Sale | 2025-03-31 | 13G | RAPT Therapeutics, Inc. RAPT | BlackRock Inc. BLK | 288,328 1.700% | -18,303 (-5.97%) | Filing |
| 2024-01-26 4:23 pm Purchase | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | BlackRock Inc. BLK | 306,631 7.100% | 68,691 (+28.87%) | Filing |
| 2023-02-01 4:54 pm Purchase | 2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | BlackRock Inc. BLK | 237,941 5.500% | 12,757 (+5.67%) | Filing |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | BlackRock Inc. BLK | 225,184 6.100% | 52,186 (+30.17%) | Filing |
| 2021-02-02 3:16 pm Purchase | 2020-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | BlackRock Inc. BLK | 172,998 5.600% | 172,998 (New Position) | Filing |